Medication compliance in ischaemic stroke patients

Internal Medicine Journal

Volumn 42, Issue 4, 2012, Pages

  Johnson, C ^a   Lane, H ^a   Barber, P A ^a   Charleston, A ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adherence; Ischaemic; Prevention; Secondary; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; GENERAL PRACTITIONER; HERBAL MEDICINE; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SECONDARY PREVENTION; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; FEMALE; GENERAL PRACTITIONERS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT DISCHARGE; QUESTIONNAIRES; SECONDARY PREVENTION; SELF MEDICATION; STROKE;

EID: 84859812098     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02209.x     Document Type: Article

References (15)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
2. Benner JS, Glynn R, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455-61.
3. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462-7.
4. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-17.
5. Ho PM, Magid D, Shetterly SM, Olson KL, Peterson PN, Masoudi FA etal. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med 2008; 168: 271-6.
6. Sturm JW, Davis SM, O'Sullivan JG, Vedadhaghi ME, Donnan GA. The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust 2002; 176: 312-16.
7. Paul SL, Thrift AG. Control of hypertension 5years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension 2006; 48: 260-5.
8. National Stroke Foundation. Clinical Guidelines for Acute Stroke Management. Melbourne: National Stroke Foundation; 2007.
9. Stroke Foundation of New Zealand. Life after Stroke. New Zealand Guidelines for Management of Stroke. Wellington: Stroke Foundation of New Zealand; 2003.
10. De Schryver ELLM, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol 2005; 252: 1316-21.
11. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-73.
12. Ho PM, Spertus J, Masoudi FA, Reid KJ, Peterson ED, Magid DJ etal. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842-7.
13. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischaemic stroke: a prospective evaluation. Stroke 2001; 32: 1884-9.
14. Bedell SE, Jabbour S, Goldberg R, Glaser H, Gobble S, Young-Xu Y etal. Discrepancies in the use of medications - their extent and predictors in an outpatient practice. Arch Intern Med 2000; 160: 2129-34.
15. Wang Y, Wu D, Wang Y, Ma R, Wang C, Zhao W. A survey on adherence to secondary ischaemic stroke prevention. Neurol Res 2006; 28: 16-20.